Measuring p50 during liver transplant surgery
This study is testing a new way to measure something called 'p50' during liver transplant surgery to see if it can help doctors better manage your care. It is for people who are having a planned liver transplant and are in relatively stable but serious health condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (elective) liver transplant surgery at Inonu University.
- Your health is rated as ASA III or IV, meaning you have a severe disease that is not dangerous right now, or a life-threatening condition.
- You are between 18 and 65 years old.
- You do not have sudden, severe liver failure, or confusion from liver disease (hepatic encephalopathy).
- You do not have kidney or lung problems caused by your liver (hepatorenal or hepatopulmonary syndrome).
- You do not have poorly controlled diabetes, serious heart or lung disease, or a severe infection (sepsis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to preserve donated livers before transplant, which may help people with severe liver disease get a transplant sooner. It may be an option for patients with certain cancers or urgent liver failure.
This study looks at how well people waiting for a liver transplant can do a simple 30-second test of standing up and sitting down. The goal is to see if this test can help doctors understand your physical strength before surgery.
This study looks at a new way to monitor blood flow in tiny blood vessels during liver transplant surgery. It may help doctors better understand how well blood is reaching tissues during the operation.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This study uses a special light-based device (near-infrared spectroscopy) to measure fat in the liver without needing extra invasive tests. It may help doctors better assess liver health before transplant or surgery.
This study tests a new way to check donated livers that other transplant centers have turned down. The goal is to see if these livers can be safely used for people on the waiting list, potentially increasing the number of available organs.
Hear when a new Liver Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.